U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06929702) titled 'Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children' on Jan. 13.
Brief Summary: The overall objective of this study is to investigate the impact of early model-informed precision dosing (MIPD) on target attainment of three beta-lactam antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam and meropenem) in critically ill children. This evaluation includes a comparison with the more standard approach on clinical and patient-oriented measures.
Study Start Date: April 22
Study Type: INTERVENTIONAL
Condition:
Amoxicillin-clavulanate
Piperacillin-tazobactam
Meropenem
Intervention:
DRUG: Beta-lactam an...